ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 024,72
0,35%
Dow Jones
38 852,27
0,46%
DAX
18 313,49
0,78%
Brent Oil
82,87
-0,72%
Bitcoin
64 036,45
1,38%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Homology Medicines Inc (FIXX)

  7. Homology Medicines Inc (FIXX) Actualités

FIXX

Homology Medicines (FIXX)

Homology Medicines Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:FIXX
DateHeureSourceTitreSymboleSociété
18/03/202421h30GlobeNewswire Inc.Homology Medicines Declares Distribution to Common StockholdersNASDAQ:FIXXHomology Medicines Inc
11/03/202412h37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:FIXXHomology Medicines Inc
11/03/202412h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FIXXHomology Medicines Inc
15/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FIXXHomology Medicines Inc
13/02/202416h11Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:FIXXHomology Medicines Inc
05/01/202423h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
03/01/202422h08GlobeNewswire Inc.Homology Medicines Receives NASDAQ Notification Regarding Minimum Bid Price DeficiencyNASDAQ:FIXXHomology Medicines Inc
11/12/202322h15Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FIXXHomology Medicines Inc
17/11/202322h05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:FIXXHomology Medicines Inc
16/11/202313h05GlobeNewswire Inc.Q32 Bio and Homology Medicines Announce Merger AgreementNASDAQ:FIXXHomology Medicines Inc
14/11/202322h33GlobeNewswire Inc.Homology Medicines Reports Third Quarter 2023 Financial ResultsNASDAQ:FIXXHomology Medicines Inc
14/08/202322h05GlobeNewswire Inc.Homology Medicines Reports Second Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
14/08/202322h01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FIXXHomology Medicines Inc
27/07/202322h05GlobeNewswire Inc.Homology Medicines Announces Plan to Evaluate Strategic Options for the Company and its Genetic Medicines Programs, including HMI-103 Gene Editing Candidate for PKUNASDAQ:FIXXHomology Medicines Inc
27/07/202322h01GlobeNewswire Inc.Homology Medicines Announces Encouraging Initial Data from First Dose Level in the pheEDIT Trial Evaluating Gene Editing Candidate HMI-103 in Adults with Classical PKUNASDAQ:FIXXHomology Medicines Inc
16/06/202301h26Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FIXXHomology Medicines Inc
14/06/202322h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FIXXHomology Medicines Inc
16/05/202314h00GlobeNewswire Inc.Homology Medicines Announces First Data from IND-Enabling Studies with GTx-mAb Candidate HMI-104 for PNH, Which Demonstrated Sustained Expression of Functional C5mAb Levels, at the ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
11/05/202322h05GlobeNewswire Inc.Homology Medicines Reports First Quarter 2023 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
11/05/202322h02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:FIXXHomology Medicines Inc
03/05/202313h30GlobeNewswire Inc.Homology Medicines Announces Upcoming Presentations Highlighting its Genetic Medicines Platform, including New Data from IND-Enabling Studies with GTx-mAb Development Candidate HMI-104 for PNH, at ASGCT Annual MeetingNASDAQ:FIXXHomology Medicines Inc
28/04/202323h58Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:FIXXHomology Medicines Inc
28/04/202322h31Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:FIXXHomology Medicines Inc
28/04/202322h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:FIXXHomology Medicines Inc
20/03/202311h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:FIXXHomology Medicines Inc
16/03/202322h04Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FIXXHomology Medicines Inc
15/03/202321h01GlobeNewswire Inc.Homology Medicines Announces Presentations on Design of Ongoing Gene Editing and Gene Therapy Trials for PKU and Hunter Syndrome at ACMG Annual Clinical Genetics MeetingNASDAQ:FIXXHomology Medicines Inc
09/03/202322h34Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:FIXXHomology Medicines Inc
09/03/202322h17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FIXXHomology Medicines Inc
09/03/202322h05GlobeNewswire Inc.Homology Medicines Reports Fourth Quarter and Full Year 2022 Financial Results and Recent HighlightsNASDAQ:FIXXHomology Medicines Inc
 Showing the most relevant articles for your search:NASDAQ:FIXX

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
EU
CS
Axa
EU
ML
Michelin
NASDAQ
MSFT
Microsoft
EU
BEL20
Bel 20
EU
EN
Bouygues
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
EU
ACA
Credit Agricole
EU
BNP
BNP Paribas
EU
MC
Lvmh Moet Hennessy Louis...
EU
SGO
Cie de SaintGobain
EU
RI
Pernod Ricard
EU
GLE
Societe Generale
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés